New DTC Rx Ad Standards Adopted

Ken Rankin
Published Online: Thursday, September 1, 2005

New industry standards governing direct-to-consumer (DTC) advertising of prescription drugs call on pharmaceutical marketers to promote health and disease awareness as part of their promotional messages.

The guidelines, developed by the Pharmaceutical Research and Manufacturers of America, also oblige drugmakers to ensure that their DTC ads "reflect a balance between risks and benefits," "be consistent with FDA-approved labeling," and "make claims only when supported by substantial evidence."

Additionally, the standards require that television ads for prescription products be "targeted for audience and age appropriateness" and include information about assistance programs for uninsured and low-income patients.

Mr. Rankin is a freelance medical writer.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues